Polygenic risk scores of several subtypes of epilepsies in a founder population

被引:15
|
作者
Moreau, Claudia [1 ]
Rebillard, Rose-Marie [2 ]
Wolking, Stefan [2 ]
Michaud, Jacques [3 ]
Tremblay, Frederique [1 ]
Girard, Alexandre [1 ]
Bouchard, Joanie [1 ]
Minassian, Berge [4 ]
Laprise, Catherine [1 ]
Cossette, Patrick [2 ]
Girard, Simon L. [1 ]
机构
[1] Univ Quebec A Chicoutimi, Ctr Intersectoriel Sante Durable, Saguenay, PQ, Canada
[2] Univ Montreal, Axe Neurosci, Ctr Rech, Montreal, PQ, Canada
[3] Univ Montreal, Ctr Rech, CHU Ste Justine, Montreal, PQ, Canada
[4] UT SouthWestern Med Ctr, Dept Pediat & Neurol & Neurotherapeut, Dallas, TX USA
关键词
GENETICS;
D O I
10.1212/NXG.0000000000000416
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectivePolygenic risk scores (PRSs) are used to quantify the cumulative effects of a number of genetic variants, which may individually have a very small effect on susceptibility to a disease; we used PRSs to better understand the genetic contribution to common epilepsy and its subtypes.MethodsWe first replicated previous single associations using 373 unrelated patients. We then calculated PRSs in the same French Canadian patients with epilepsy divided into 7 epilepsy subtypes and population-based controls. We fitted a logistic mixed model to calculate the variance explained by the PRS using pseudo-R-2 statistics.ResultsWe show that the PRS explains more of the variance in idiopathic generalized epilepsy than in patients with nonacquired focal epilepsy. We also demonstrate that the variance explained is different within each epilepsy subtype.ConclusionsGlobally, we support the notion that PRSs provide a reliable measure to rightfully estimate the contribution of genetic factors to the pathophysiologic mechanism of epilepsies, but further studies are needed on PRSs before they can be used clinically.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Polygenic Risk Scores: What Are They Good For?
    Zheutlin, Amanda B.
    Ross, David A.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (11) : E51 - E53
  • [42] Polygenic Risk Scores in Breast Cancer
    Lida A. Mina
    Banu Arun
    Current Breast Cancer Reports, 2019, 11 : 117 - 122
  • [43] Polygenic risk scores: a biased prediction?
    De La Vega, Francisco M.
    Bustamante, Carlos D.
    GENOME MEDICINE, 2018, 10
  • [44] Polygenic Risk Scores for Breast Cancer
    Demarest, Kaitlin
    Shah, Payal D.
    CURRENT BREAST CANCER REPORTS, 2024, 16 (02) : 269 - 277
  • [45] Polygenic risk scores and rheumatic diseases
    Brown, Matthew A.
    Li, Zhixiu
    CHINESE MEDICAL JOURNAL, 2021, 134 (21) : 2521 - 2524
  • [46] THEORY AND APPLICATIONS OF POLYGENIC RISK SCORES
    Dudbridge, Frank
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S109 - S109
  • [47] Polygenic risk scores for CARDINAL study
    Clement A. Adebamowo
    Adebowale Adeyemo
    Adeyinka Ashaye
    Onoja M. Akpa
    Tinashe Chikowore
    Ananyo Choudhury
    Yasmina J. Fakim
    Segun Fatumo
    Neil Hanchard
    Michael Hauser
    Braxton Mitchell
    Nicola Mulder
    Solomon F. Ofori-Acquah
    Mayowa Owolabi
    Michèle Ramsay
    Bamidele Tayo
    Archana Bhavani VasanthKumar
    Yuji Zhang
    Sally N. Adebamowo
    Nature Genetics, 2022, 54 : 527 - 530
  • [48] Polygenic risk scores in prostate cancer
    Eeles, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1054 - 1055
  • [49] Bringing polygenic risk scores to the clinic
    Hannah Stower
    Nature Medicine, 2018, 24 : 1303 - 1303
  • [50] Polygenic Risk Scores and Genetics in Psychiatry
    Kalin, Ned H.
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (11): : 781 - 784